Approaches to Addressing Pediatric Cancer Treatment Refusal Beyond Legal Action (opens in a new tab)
Pediatr Blood Cancer
Treatment Refusal
Dr. Daniel Joseph Benedetti, MD
NPI1174822985PAC ID3577782655
- Publications
- 43
- Clinical trials
- 5
- Hospital affiliations
- 1
- Medical group
- 1
- Insurance carriers
- 16
- Practice address
- 1211 Medical Center Drive, Nashville, TN 37232
- Practice phone
- Call (615) 322-3454
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Benedetti's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel Joseph Benedetti is a pediatric hematology and oncology physician in Nashville, Tennessee
Dr. Benedetti practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.
Dr. Benedetti's NPI, 1174822985, was assigned on March 18, 2011. Dr. Benedetti graduated from University Of Washington School Of Medicine in 2011. Dr. Benedetti holds Tennessee license 57896.
NPI and contact details
- NPI
- 1174822985NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3577782655
- NPI enumeration date
- March 18, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (615) 322-3454
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel Joseph Benedetti practices at Vanderbilt University Medical Center in Nashville, Tennessee
Dr. Benedetti's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.
- Vanderbilt University Medical Center1211 Medical Center Drive, Nashville, TN 37232 · Davidson CountyPhone(615) 322-3454
Source: Dmand AI Affiliation Data
Dr. Daniel Joseph Benedetti is affiliated with 2 sites of care and 1 medical group
Dr. Benedetti's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Benedetti to 1 more group practice or clinic, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Daniel Joseph Benedetti's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benedetti practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Vanderbilt University Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Benedetti practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Vanderbilt University Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel Joseph Benedetti is one of 141 pediatric hematologys and oncology physicians in Tennessee
Pediatric hematology-oncology is Dr. Benedetti's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Benedetti is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Benedetti's licenses on file in 4 states: Tennessee, Alabama, Massachusetts and Washington.
Specialties and state licenses
- Pediatric hematology and oncology, TennesseePrimary
- Alabama license
- Massachusetts license
- Washington license
Pediatric hematologys and oncology physicians near Dr. Benedetti
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
141pediatric hematologys and oncology physicians in Tennessee22pediatric hematologys and oncology physicians in Nashville16pediatric hematologys and oncology physicians at Vanderbilt University Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel Joseph Benedetti's patients have a median age of 9
Across all payers, Dmand AI patient panel data puts Dr. Benedetti's median patient age at 9, with 57% women.
Dr. Benedetti's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 9
Patient panel by sex, all payers
- Women57%
- Men43%
Source: Dmand AI Patient Panel Data
How Dr. Daniel Joseph Benedetti takes part in Medicare
Dr. Benedetti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel Joseph Benedetti has 43 publications on record
Dmand AI links 43 papers to Dr. Benedetti, published from 2017 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Kidney Neoplasms, Wilms Tumor and Liver Neoplasms. Dr. Benedetti has published most often in Pediatr Blood Cancer. Dr. Benedetti's most frequent co-authors are Peter Frederick Ehrlich, MD, Elizabeth A. Mullen, FAAP, MD and Jeffrey S. Dome, MD.
Papers43
Years published2017 to 2025
Dr. Benedetti's papers by year, 2017 to 2025
Topics Dr. Benedetti writes about most
- Kidney Neoplasms
- Wilms Tumor
- Liver Neoplasms
- Medical Oncology
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Hepatocellular
- Hepatectomy
- Liver Transplantation
Dr. Benedetti's most frequent co-authors
- Peter Frederick Ehrlich, MD8 shared papers
- Elizabeth A. Mullen, FAAP, MD8 shared papers
- Jeffrey S. Dome, MD7 shared papers
Recent publications by Dr. Benedetti
See who Dr. Benedetti researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Benedetti works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Daniel Joseph Benedetti has worked on 5 clinical trials
Dmand AI links Dr. Benedetti to 5 clinical trials, 2 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Neuroblastoma, Ganglioneuroblastoma and Angiolipoma. Children's Oncology Group sponsors the most, 5.
Clinical trials with Dr. Benedetti by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Benedetti's trials
- Neuroblastoma
- Ganglioneuroblastoma
- Angiolipoma
- Fibrolamellar hepatocellular carcinoma
- Hepatoblastoma
Investigators on the most trials with Dr. Benedetti
- Ramamoorthy Nagasubramanian, MD4 shared trials
- Minnie Abromowitch, MD3 shared trials
- Robert M. Cooper, MD3 shared trials
Recent clinical trials with Dr. Benedetti
Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) (opens in a new tab)
Active, not recruitingPhase 2
GanglioneuroblastomaNeuroblastomaDinutuximabIrinotecanIsotretinoin
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma (opens in a new tab)
Active, not recruitingPhase 2
NeuroblastomaNeuroectodermal Tumors, Primitive, PeripheralDinutuximabIrinotecan HydrochlorideTemozolomide
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery (opens in a new tab)
Active, not recruitingPhase 3
Fibrolamellar hepatocellular carcinomaHepatoblastomaCisplatinCarboplatinDoxorubicin
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) (opens in a new tab)
Active, not recruitingPhase 3
GanglioneuroblastomaNeuroblastomaLorlatinibBusulfanCarboplatin
Study of Kidney Tumors in Younger Patients (opens in a new tab)
Active, not recruiting
AngiolipomaOncocytoma, renal
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Daniel Joseph Benedetti graduated from University Of Washington School Of Medicine
Dr. Benedetti graduated from University Of Washington School Of Medicine in 2011.
- Medical school
- Board certified in pediatric hematology-oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Daniel Joseph Benedetti accepts plans from 16 insurance carriers
Dr. Benedetti is in network with 16 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
- United Healthcare
- Aetna
- Blue Cross Blue Shield of Michigan
- Elevance
- HCSC
- Alliant Health Plans
- Aspirus Health Plan
- AK State Medicaid
- +8 more carriersWith a free account
Plan types Dr. Benedetti accepts, by number of carriers
- HMO7
- PPO7
- Medicaid5
- EPO4
- POS4
- Medicare2
Source: Dmand AI Insurance Network Data
Sources for Dr. Daniel Joseph Benedetti's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel Joseph Benedetti
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel Joseph Benedetti's NPI number?
Dr. Daniel Joseph Benedetti's NPI number is 1174822985. It was assigned on March 18, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel Joseph Benedetti?
Dr. Daniel Joseph Benedetti is a pediatric hematology and oncology physician in Nashville, Tennessee. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Daniel Joseph Benedetti practice?
Dr. Benedetti practices at 1211 Medical Center Drive, Nashville, TN 37232. Dr. Benedetti's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dmand AI also links Dr. Benedetti to 1 group practice or clinic.
What is Dr. Daniel Joseph Benedetti's office phone number?
The practice phone on file for Dr. Benedetti is (615) 322-3454.
What is Dr. Daniel Joseph Benedetti's medical license number?
Dr. Benedetti holds Tennessee license 57896, one of the licenses on file in 4 states.
Which states has Dr. Daniel Joseph Benedetti been licensed in?
Dmand AI has state licenses on file for Dr. Benedetti in Tennessee (2018 to 2027), Alabama (2020), Massachusetts (2015 to 2020) and Washington (2011 to 2016).
Which hospitals is Dr. Daniel Joseph Benedetti affiliated with?
Dr. Benedetti practices at Vanderbilt University Medical Center in Nashville, Tennessee.
What medical group is Dr. Daniel Joseph Benedetti part of?
Dr. Benedetti is linked to Vanderbilt University Medical Center.
Does Dr. Daniel Joseph Benedetti accept Medicare?
Yes. CMS lists Dr. Benedetti as accepting Medicare assignment.
Is Dr. Daniel Joseph Benedetti board certified?
Yes. Dr. Benedetti is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Show 5 more questionsShow fewer questions
Where did Dr. Daniel Joseph Benedetti go to medical school?
Dr. Benedetti graduated from University Of Washington School Of Medicine in 2011.
How long has Dr. Daniel Joseph Benedetti been practicing?
Dr. Benedetti graduated from medical school in 2011, 15 years ago.
Does Dr. Daniel Joseph Benedetti do research?
Dmand AI links 43 publications to Dr. Benedetti, published from 2017 to 2025. Dr. Benedetti has worked on 5 clinical trials.
Who does Dr. Daniel Joseph Benedetti publish with?
Dr. Benedetti's most frequent co-authors are Peter Frederick Ehrlich, MD (8 shared papers), Elizabeth A. Mullen, FAAP, MD (8 shared papers) and Jeffrey S. Dome, MD (7 shared papers).
What insurance does Dr. Daniel Joseph Benedetti accept?
Dr. Benedetti is in network with 16 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card